Prognostic Value of Baseline Computed Tomography (CT) Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical Resection

NCT01326364 · clinicaltrials.gov ↗

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

PROCEDURE: Stereotactic body radiotherapy
DRUG: Iodixanol
DRUG: Iohexol

Sponsor

Stanford University